drugset / Trial / NCT03590262

Effect of Metformin as add-on Therapy on Glycemic Control and Other Outcomes in Type 1 Diabetes

NCT03590262 ↗

Phase 4 Unknown 20 enrolled Shenzhen People's Hospital
NaSingle-groupOpen-labelTreatment

Summary

Aim Evidence of a possible connection between gut microbiota and several physiological processes linked to type 1 diabetes is increasing. However, the effect of multistrain probiotics in people with type 1 diabetes remains unclear. This study investigated the effect of metformin as add-on therapy on glycemic control and other diabetes-related outcomes in people with type 1 diabetes.

Timeline

Start
2018-01-01
Primary completion
2019-03-31
Completion
2019-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 500 mg —